Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, flags a substantial new fund available for MedTech start-ups and scale-ups.
The UK Government’s Department for Science, Innovation and Technology has announced the appointment of Kenan Poleo as Director of the Office for Life Sciences from 1st May.
As Director, Mr Poleo will lead the cross-government delivery of the Life Sciences Sector Plan and support the innovation commitments in the 10 Year Health Plan – translating strategic ambitions into real-world impact by accelerating innovation into the NHS, unlocking investment, and driving regulatory reform, with a target to be the third most important life sciences economy globally by 2035.
Poleo was previously appointed the Consul General and Trade Commissioner for Eastern Europe and Central Asia from 1 September 2021 to 28 February 2026. Prior to being appointed to Istanbul, he was Deputy Trade Commissioner for Europe, based in Berlin, Germany.
His previous roles include Head of Global at Innovate UK, supporting business led innovation and international collaboration, and Regional Director for the UK Science and Innovation Network for Europe, Russia and Turkey at the FCDO, also based at the British Embassy in Berlin.
The Author used AI in preparing this article. Comments upon or questions about this article can be addressed to chris.whitehouse@whitehousecomms.com.
